U.S. markets open in 1 hour 53 minutes
  • S&P Futures

    4,382.00
    +33.75 (+0.78%)
     
  • Dow Futures

    34,128.00
    +289.00 (+0.85%)
     
  • Nasdaq Futures

    15,118.50
    +109.00 (+0.73%)
     
  • Russell 2000 Futures

    2,201.10
    +24.30 (+1.12%)
     
  • Crude Oil

    71.16
    +0.87 (+1.24%)
     
  • Gold

    1,767.10
    +3.30 (+0.19%)
     
  • Silver

    22.53
    +0.33 (+1.49%)
     
  • EUR/USD

    1.1741
    +0.0014 (+0.12%)
     
  • 10-Yr Bond

    1.3090
    0.0000 (0.00%)
     
  • Vix

    23.09
    +2.28 (+10.96%)
     
  • GBP/USD

    1.3679
    +0.0020 (+0.14%)
     
  • USD/JPY

    109.4090
    -0.0110 (-0.01%)
     
  • BTC-USD

    43,505.85
    -634.18 (-1.44%)
     
  • CMC Crypto 200

    1,092.59
    -41.80 (-3.68%)
     
  • FTSE 100

    6,980.77
    +76.86 (+1.11%)
     
  • Nikkei 225

    29,839.71
    -660.34 (-2.17%)
     

Sensus Healthcare Announces Participation in A.G.P.’s Virtual MedTech Summer Conference on July 29, 2021

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

BOCA RATON, Fla. , July 22, 2021 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, today announced that management will participate in A.G.P.’s Virtual MedTech Summer Conference on Thursday, July 29, 2021.

The event will consist of one-on-one virtual investor meetings. Investors participating in the virtual conference who are interested in meeting with members of Sensus Healthcare’s management team should contact their A.G.P. representative.

About Sensus Healthcare

Sensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for both oncological and non-oncological conditions. The Sculptura™ modulated robotic brachytherapy radiation oncology system provides targeted Directional Anisotropic Radiation Therapy (ART) and Brachytherapy utilizing our proprietary, state-of-the-art 3D Beam Sculpting™ to treat patients undergoing cancer treatment during surgery, or at the tumor site, fast and efficiently. Sensus also offers its proprietary low-energy X-ray technology known as superficial radiation therapy (SRT), which is the culmination of more than a decade of research and development, to treat non-melanoma skin cancers and keloids with its SRT-100™, SRT-100+™ and SRT-100 Vision™ systems. With its portfolio of innovative medical device products, Sensus provides revolutionary treatment options to enhance the quality of life of patients around the world.

For more information, visit www.sensushealthcare.com.

Contact:

LHA Investor Relations
Kim Sutton Golodetz
212-838-3777
kgolodetz@lhai.com

# # #